Skip to main content

Pharmaceutical Sciences Notes

Pharmaceutical Sciences Notes, PST Level 6 Semester 1, PST NTA Level 6, PST06104 Health and Medicine Policy

PST06104 Health and Medicine Policy – Complete Full Notes

/

NTA Level 6 • Semester 1 • PST06104 Health and Medicine Policy – Complete Full Notes Complete educational source text in one page Completeness safeguard: this page keeps the complete educational module/source wording in one place so learning material is not lost when browsing topic by topic. Presenter/tutor metadata is intentionally excluded. Session 1: Introduction to Health System in Tanzania 1 Learning Tasks By the end of this session students are expected to be able to: Define terms related to health system State the vision and mission of the MoHCDGEC List levels of health care in Tanzania List roles of the MoHCDGEC (Ministry of Health, Community Development, Gender, Elderly and Children) in Health care System in Tanzania 2 Definition of Terms Related to Health System Health is a state of complete physical, mental, and social well being, and not merely the absence of disease or infirmity. (WHO) Policy is a law, regulation, procedure or administrative action created by government or non-government institution Health policy is a visionary program of action adopted by the government to have a healthy society, with improved social wellbeing that will contribute effectively to personal and national development. 3 Definitions Cont… Medicines Policy is a written document specifying the medium – to long – term goals set by the government for the pharmaceutical sector, their relative importance, and their main strategies for attaining them. It is a political commitment to a goal and a guide for action. It provides a framework for coordinating activities for pharmaceutical sector. 4 Vision and Mission of Ministry of Health in Health and Medicine system Vision To improve health and wellbeing of all Tanzanian, with a focus on those most at risk, and to encourage the health system to be more responsive to the needs of the people 5 Cont… Mission To facilitate the provision of basic health services that are good, quality, equitable, accessible, affordable, sustainable and gender sensitive 6 Levels of Health Care in Tanzania Community health services Dispensaries: village/ street level Health centres: ward level District hospitals: district level Regional/referral hospitals: regional level (are consultant hospitals) National, Consultant and specialized hospitals: national level 7 Community Health Services It is the responsibility of each individual and/or household to take care of its own health Village Government should recognize and enhance the essential role of communities in directing local health services. The community will have the mandate to choose their own community health worker who will be the main linkage between the community and the nearest health facility. 8 Dispensary Services This is the first formal health unit of level one health services. It is a primary health facility which offers outpatient services including reproductive and child health services, and diagnostic services. A dispensary caters for 5,000 people and oversees all the village health services. Dispensaries shall provide primary health care services to the community. Refer the references to identify the primary health services to be provided at dispensary level 9 Health Center Services This is the second formal health unit of level one-health services. It is a primary health facility, which offers Outpatient and In-patient services, maternity care, laboratory, dispensing and mortuary services. A Health Centre shall cater for 50,000 people and supervise all the dispensaries in the Division. 10 District Hospital Services It is also a level one health services and plays the following roles: Out-patient and In-patient care Act as the second referral level f or the primary health care facilities in the district or catchment’s area Perform general surgical and obstetric operations Conduct teaching, training and research programs in the district concerning community health Give supportive supervision and inspection and provide technical skills to lower health facilities in the district and refers patients to the regional hospital. 11 Regional Hospital Services This is a hospital establishment providing level two (Secondary) referral services from level one hospital This level have the following functions: To provide all services offered at district level but at a higher level of expertise Conduct health research programs in the Region Provide technical skills to lower health facilities in the Region and offer specialized treatment in Medicine, Surgery, Obstetrics and Gynaecology and Paediatric, and shall include Eye, Dental, Mental illnesses, Orthopaedics and Trauma 12 National, Consultant and Specialized Hospital Services This is level three and the highest level of hospital services in the country It acts as referral centre for level two hospitals. 13 National Hospital Muhimbili is the currently national hospital It also acts as Eastern zonal referral hospital 14 Zonal Consultant Hospitals At present there are four zonal referral or consultant hospitals. Muhimbili National Hospital Two voluntary agency hospitals: Bugando Medical Centre and Kilimanjaro Christian Medical Center (KCMC) Mbeya Referal Hospital (owned by the government) 15 Specialized Hospitals There are two specialized hospitals Mirembe Hospital (Dodoma) and Kibongoto ( Moshi ) They provide services to the mentally sick and TB patients respectively 16 Roles of the MoH in Health and Medicine Policy Policy formulation, health legislation, regulation and control Resource mobilization and allocation Management support of level three hospitals including National, Consaltant and Special Hospitals Supervision and Monitoring of special and Consultant Hospitals owned by NGOs Monitoring and evaluation of health services countrywide Activity: Use the given references for extra roles of MoH 17 Key Points Health Policy is important in a country like ours where resources and technology are more limited than in other countries. Medicines Policy is a written document specifying the medium – to long – term goals set by the government for the pharmaceutical sector, their relative importance, and their main strategies for attaining them. MoHCDGEC mission is to facilitate the provision of basic health services that are good, quality, equitable, accessible, affordable, sustainable and gender sensitive 18 Review Questions What is the vision and mission of the MoH of health care in Tanzania? What are the levels of health care in Tanzania. 19 References URT (2007): The National Health Policy , Dar es Salaam, Tanzania. Government Printer URT (2016): Task sharing policy guidelines for health

Soma Makala →
Pharmaceutical Sciences Notes, PST Level 6 Semester 1, PST NTA Level 6, PST06105 Health Financing

PST06105 Health Financing – Complete Full Notes

/

NTA Level 6 • Semester 1 • PST06105 Health Financing – Complete Full Notes Complete educational source text in one page Completeness safeguard: this page keeps the complete educational module/source wording in one place so learning material is not lost when browsing topic by topic. Presenter/tutor metadata is intentionally excluded. PST 06105: HEALTH FINANCING Session 1: Introduction to Health Financing Learning Tasks At the end of this session students are expected to be able to : Explain the historical background of health financing Describe various concepts of health financing Historical Background of Health Financing H ealth financing has been one of the most important policy agenda nationally and internationally among health leaders and policy-makers. Health financing has risen on agenda of policy- makers due to the fact that health systems , especially developing countries, are facing what is known as a problem of financial (fiscal) sustainability. Historical Background of Health Financing Problem of financial sustainability: exists when health system or government is unable to meet its obligations due to its inability or unwillingness to generate sufficient revenue to meet them . Historical Background of Health Financing Key symptoms of the problem of financial sustainability: ( World Bank, 1987, 1993): Misallocation and insufficient spending on cost-effective health interventions needed by the population: public money was/is spent on health interventions of low cost effectiveness Internal inefficiency: much of the money spent on health is wasted: brand-name pharmaceuticals are purchased instead of generic drugs, health workers are badly deployed and supervised, and hospital beds are underutilized. Historical Background of Health Financing Key symptoms of the problem of financial sustainability: ( World Bank, 1987, 1993): Inequity in the distribution of benefits from health services: The better-off in most had and continue to have better access to health care ; the poor lack access to basic health services and receive low-quality care Difficulty in achieving or maintaining acceptable quality services within the government budget Historical Background of Health Financing As result of these problems, world bank and others proposed health sector reforms policies that were intended to improve performance of health systems; These reforms, among, other recommended that health financing should be strengthening by introducing the following: new financing mechanisms such as user fees, health insurance and other sick coverage; and improved management of public health services. Activity: Brainstorming What is the meaning of the term “health financing” and “sources of finances”? 8 Health financing is defined variously by different experts: R efers to collection of funds from various sources (e.g . government, individual, businesses, donors); pooling fund to share financial risks across larger population groups; and using them to pay for services from public and private health-care providers. (WHO, 2000) Is the process by which revenues are collected from primary and secondary sources, accumulated in fund pools and allocated to provider activities. ( Mossialos et al,2003 ), It is defined also as a process of raising financial resources to finance and pay for health services Sources of finances T he main sources of finances for health care are: Individuals , households and employees Firms , corporate entities and employers Foreign and domestic NGO‟s and charities Foreign governments, companies multilateral agencies Contribution Mechanisms The contribution mechanisms are the ways in which individuals, households, firms and governments do contribute funds to collecting agents. The main contributing mechanisms are : Direct and indirect taxes Compulsory insurance premiums Voluntary insurance premiums Out-of-pocket payment(user charges) Donations , grants and loans Medical savings accounts Importance or significance of health financing The importance or significance of health financing has been stated by WHO (2003) as follows : Adequate and sustained financing is a critical factor in the creation of a viable health system . Fair financing mechanisms allow people to access health services at the right time and prevent people against impoverishment Financing is the mechanism by which plans and policies are translated into action through the allocation of resources Importance or significance of health financing Without adequate financing, plans remain in the realm of rhetoric and good intentions With adequate financing, a resource base can be created for the operations and delivery of services, the development and deployment of a trained workforce and the required infrastructure and technology Financing is a fundamental building block on which the other critical aspects (services, human resources, medicines and equipment, health information and leadership and management) of the health system rest Also, financing is a powerful tool with which policy-makers can develop and shape health services and their impact in improving health of the population Key points Health financing is an important topic and sub-component of health system that facilitate delivery of health service and improvement of health of the population There are number of concepts that need to be understood for better understanding of health financing Evaluation What is the meaning of the following terms h ealth financing, health financing functions, sources of finance, contributing mechanism, and financing option/ mechanism What are the symptoms the problem of financial sustainability? Reference Gottret , P. Schieber , G. (2006). Health financing revisited: a practioner’s guide. Washington DC , USA. World Bank Green , A. (2007). An introduction to health planning for developing countries (3rd Ed.) London : Oxford University Press. Gruen , R and Howarth , A. (2005). Financial management for health services. London: Open University . Jiyenze , M. K. (2013). Health care financing and resource allocation: handout for teaching health care financing. Arusha : CEDHA. [Notes: Unpublished] Kutzin , J (2001). A descriptive framework for country-level analysis of health care financing arrangements . Health Policy; 56, 171–204. Reference Tanzania . MoHSW (2014). DHM Healthcare financing module. Dar es Salaam: MoHSW . Mossialos , et al ( ed ) (2002). Funding health care: options for Europe. Buckingham: Open University Press. WHO (2003). Mental health financing. Geneva. Switzerland: WHO. World Bank (1987). Financing health services in developing countries: an agenda for reform . Washington, D.C: World Bank ,. World Bank (1993). World Development Report 1993: investing in health. Oxford, UK: Oxford University Press. PST

Soma Makala →
Pharmaceutical Sciences Notes, PST Level 6 Semester 1, PST NTA Level 6, PST06106 Basic Pharmacotherapy

PST06106 Basic Pharmacotherapy – Complete Full Notes

/

NTA Level 6 • Semester 1 • PST06106 Basic Pharmacotherapy – Complete Full Notes Complete educational source text in one page Completeness safeguard: this page keeps the complete educational module/source wording in one place so learning material is not lost when browsing topic by topic. Presenter/tutor metadata is intentionally excluded. PST 06106 BASIC PHARMACOTHERAPY Session 1: Introduction to Pharmacotherapy Learning objectives By the end of this session students are expected to be able to: Define terminologies used in Pharmacotherapy Describe principles and concepts applied in Pharmacotherapy Explain importance of Pharmacotherapy in the management of common diseases Definition of Common Terminologies used in Pharmacotherapy Pharmacotherapy is application of knowledge in making therapeutic decisions that are most likely to have maximum positive benefit for a specific patient. Pharmacotherapy specialist: is an individual who is specialized in administering and prescribing medication, and requires extensive academic knowledge in pharmacotherapy. Pharmaceutical personel are experts in pharmacotherapy and are responsible for ensuring the safe, appropriate, and economical use of pharmaceutical drugs. Definition of Common Terminologies used in Pharmacotherapy Cont.….. Pathophysiology is the physiology of abnormal states; specifically: the functional changes that accompany a particular syndrome or disease. Also is the study of changes in the way the body works that result from disease or injury Pharmaceutical care involves the process through which a pharmacist/ other pharmaceutical personnel cooperates with a patient and other professionals in designing, implementing, and monitoring a therapeutic plan that will produce specific therapeutic outcomes for the patient Principles and Concepts applied in pharmacotherapy There are three steps that are involved in the Pharmacotherapy process which are ; Patient assessment Development of the pharmacotherapy care plan Evaluation of the impact or results of the care plan Principles and Concepts applied in pharmacotherapy Cont ….. Fig 1.1 Patient Care Process in the Pharmacotherapy Patient Assessment The focus is on drug therapy problems in which case it is important to assess if the patient’s problem(s) is/are be caused by drug therapy and can be managed by a change in drug therapy The following is the list of drug therapy problems that should be identified; Inappropriate drug selection, Need for additional drug therapy Unnecessary drug therapy Incorrect drug regimen Therapeutic duplication Drug allergy/adverse drug event Drug Interactions Medication adherence issues Patient Assessment Cont ….. Once a drug therapy problem is identified and categorized, it is then necessary to identify the cause of the problem, thereby leading to potential solutions. The process of drug therapy problem identification is to assessing the patient’s drug therapy needs and ensuring appropriateness, effectiveness and safety of medications, and the patient’s adherence Pharmacotherapy Care Plan The pharmacotherapy care plan is important in order to achieve improved pharmacotherapy outcomes. It is the action plan developed from assessment of patient described above. Each item in the patient’s problem list must be addressed in the care plan, and the care plan should be prioritized in the same way as the problem list. The pharmacotherapy care plan has several key components for each problem: Current drug regimen Drug therapy problems Therapy goals, desired endpoints Pharmacotherapy Care Plan Cont … The goals of therapy must be achievable and realistic for the patien Drug therapy may aim to cure a disease; reduce or eliminate signs and/or symptoms slow or halt the progression of a disease prevent a disease normalize laboratory values and/or assist in the diagnostic process Therapeutic recommendations Rationale Therapeutic alternatives Monitoring Pharmacotherapy Care Plan C ont … Monitoring helps in determining whether treatment goals and endpoints (achieving positive goals and avoiding negative endpoints) are being reached. An effective monitoring plan must be realistic for the patient setting and include specific monitoring parameters (clinical and laboratory/diagnostic test) frequency of monitoring, and When the patient needs to be seen again for follow-up. Patient education Evaluation The patient care process involves continuous follow-up. As the pharmacotherapy care plan is implemented, the patient’s response to therapy is monitored, and changes in therapy may be necessary. Changes in previous problems or the development of new signs and symptoms will require the assessment process and changes in the pharmacotherapy care plan During the Pharmacotherapy process, it is important to consider/review the following factors for optimal therapeutic outcome ; Evaluation Cont ……. Patient Dermographics —name, age, etc. Chief Complaint—why the patient is seeking help, in the patient’s own words History of Present Illness (HPI)—the patient’s story about why they are seeking help Past Medical History (PMH)—including all significant illnesses, surgical procedures, injuries Family History—age and health of immediate family (parents, siblings, children); for deceased relatives, the age and cause of death are included; any hereditary diseases should be noted E valuation Cont ……. Social History—may include where the patient is from or lives, ethnicity/race, marital status, number of children, educational background, occupation, diet Tobacco/Alcohol/Substance Use Allergy/Intolerances/Adverse Drug Events (ADEs)—a common area where information from the patient is missing or incomplete Medication History—should include current (or medications prior to admission if hospitalized) and previous medications; the list should include what the patient actually is taking, not just what is prescribed, and must include OTC drugs and dietary supplements (including herbal and complementary/alternative products ). Evaluation Cont ……. Signs and symptoms Laboratory and Other Diagnostic Tests Diagnosis . Treatment (Drug) plan Follow-up plan Activity: Small Group Discussion What is the importance of Pharmacotherapy? Importance of pharmacotherapy Helps in optimization of drug treatment in complex pharmacotherapy patients such as; Patients with multiple medications Patients with multiple disease states or conditions Patients on narrow therapeutic index medications Patients on medications requiring laboratory monitoring Helps in optimization of drug therapy in patients with high risk for loss of continuity of care such as; Patients with multiple prescribers Patients with recent transitions of care (e.g., hospital discharge, rehabilitation, skilled nursing facility discharge) Importance of pharmacotherapy cont… Helps in reduction of medication nonadherence especially in patients with; Irregular refill history History of failure to pick up new prescriptions Stockpiling or incorrect pill counts Financial burden (e.g., uninsured or underinsured) Low health literacy Patient’s beliefs indicate resistance to treatment High-cost

Soma Makala →
Pharmaceutical Sciences Notes, PST Level 6 Semester 1, PST NTA Level 6, PST06107 Basic Veterinary Pharmacology

PST06107 Basic Veterinary Pharmacology – Complete Full Notes

/

NTA Level 6 • Semester 1 • PST06107 Basic Veterinary Pharmacology – Complete Full Notes Complete educational source text in one page Completeness safeguard: this page keeps the complete educational module/source wording in one place so learning material is not lost when browsing topic by topic. Presenter/tutor metadata is intentionally excluded. PST 06107 Basic Veterinary Pharmacology Session 1: Introduction to Veterinary Pharmacology Learning Tasks By the end of this session students are expected to be able to: Define terminologies used in veterinary pharmacology Outline the therapeutic classes of veterinary medicines Describe principles and concepts applied in veterinary pharmacology Explain the sources veterinary medicines Outline the basic concepts in veterinary toxicology Explain the importance of veterinary pharmacology in the management of common animal diseases General Principles and Concepts of Veterinary Pharmacology and Toxicology Veterinary Pharmacology is the study of substances that interact with living systems through chemical processes, especially by binding to regulatory molecules and activating or inhibiting normal body processes in animals Veterinary pharmacology is concerned with the use of drugs for diseases and health problems unique to animals The sources of veterinary medicines are also similar to the sources of human medicines namely plants, animals, minerals and synthetic sources General Principles and Concepts of Veterinary Pharmacology and Toxicology Cont … The therapeutic classes of veterinary medicines include antibiotics, antifungal, antiviral, anti-inflammatory drugs, growth promoters, ant parasitic drugs, insecticides and tranquilizers The principles and concepts of veterinary pharmacology are similar to human pharmacology They involve Pharmacokinetics and Pharmacodynamics General Principles and Concepts of Veterinary Pharmacology and Toxicology Cont … Pharmacodynamics is the study of cell/tissue responses and selective receptor effects. The significant difference in veterinary pharmacology is the species variations that need to be considered These variations have significant influence on pharmacokinetics and pharmacodynamics of veterinary medicines Toxicology is the study of poison and their effects on normal physiologic mechanisms General Principles and Concepts of Veterinary Pharmacology and Toxicology Cont … It is important to understand the more commonly encountered toxins and to treat affected animals accordingly When treating an intoxicated animal, the general rule to remember is that, “ treat the animal not the poison ” Toxicity is the quality of being poisonous (dose of poison that elicits a response) Toxicosis is the clinical syndrome associated with exposure to a poison e.g. acetaminophen toxicosis General Principles and Concepts of Veterinary Pharmacology and Toxicology Cont … Toxins that affect the more commonly domestic species are extremely diverse The types of toxins often encountered include; Metals, mycotoxins , feed-related intoxications, pharmaceutical agents, pesticides (insecticides, herbicides), biotoxins (plants, poisononous animals and insects, bacterial toxins) For toxicosis to occur, there must be a dose-related response, the greater the dose the more likely that toxicosis will occur General Principles and Concepts of Veterinary Pharmacology and Toxicology Cont … Some toxins exhibit a steep dose-response relationship and are considered highly toxic To cause intoxication, a substance must be absorbed and delivered to the site of action at a concentration high enough to elicit a physiologic response e.g. presence of a poisonous plant in a pasture is not enough; there must be evidence of consumption of these plants Different animals in a herd may consume different plants or forage There are individual and species variations in susceptibility to toxins The clinical signs observed must correlate with the suspect plant General Principles and Concepts of Veterinary Pharmacology and Toxicology Cont … Toxicokinetics This is the study of the metabolic processes that occur after exposure to a toxin (absorption, distribution, biotransformation, and elimination) It involves the mathematical description of the movement of a toxin into the body (absorption), to the target organs (distribution) and out of the body (elimination) Concentration of a toxin at the site of action depends on; Dose, physicochemical properties of the toxin or drug, absorption, distribution, specific tissue affinity, rate of metabolism, rate of elimination General Principles and Concepts of Veterinary Pharmacology and Toxicology Cont … The fate after exposure to toxins is influenced by; Toxins or drug factors Host factors or physiologic factors There are animal factors including age, organ perfusion, organ function (hepatic, renal), membrane permeability, pH of tissue or compartment, species and gastrointestinal anatomy and physiology Activity: Small Group Discussion What is pharmacokinetics? General Principles and Concepts of Veterinary Pharmacology and Toxicology Cont … Pharmacokinetics is the study of drug absorption, distribution, biotransformation (metabolism), and excretion Pharmacokinetic processes affect the route of administration, doses, dose intervals, and toxicities of drugs given to animals The following are the importance's of Veterinary Pharmacology Helps in understanding the mechanism of action of veterinary medicines Helps in the determination of correct indication and dosage of veterinary medicines Helps to identify and respond to drug interactions, contraindications and adverse drug reactions related to veterinary medicines accordingly Helps in understanding of the disposition processes in the body including absorption, distribution, metabolism and elimination of veterinary medicines These will help students learning veterinary pharmacology to dispense right drug to the right animal, at right dose, by right route and at right time Key Points Veterinary pharmacology is the study of medicines which are used in animals, poultry and fish Principles and Concepts of Veterinary Pharmacology includes pharmacokinetics and pharmacodynamics Veterinary Pharmacology is important in the pharmacological treatment of veterinary diseases Toxicology is the study of poison and their effects on normal physiologyic mechanisms Evaluation What is veterinary pharmacology? What are principles and concepts of veterinary pharmacology? What is importance of veterinary pharmacology? What is toxicology? References Riviere J. E., Papich M. G. (2009). Veterinary Pharmacology and Therapeutics (9th Ed) Iowa, Wiley- Blackwel Publishers Hsu W. H. (2008). Handbook of Veterinary Pharmacology (1st Ed) Iowa, Wiley- Blackwel Publishers Kuafmann J, (1996). Parasitic infections of domestic animals , (2nd ed ).Berlin, Birkhäuser Verlag Press Hoare E. W. (2013). A manual veterinary therapeutics & pharmacology (2nd ed ),New York, Forgotten Books Press Maddison . J. ( ed ) (2008 ). Small Animal Clinical Pharmacology , (2nd ed ). Philadelphia, Saunders Elsevier Limited PST 06107 Basic Veterinary Pharmacology Session 2: Variation

Soma Makala →
Pharmaceutical Sciences Notes, PST Level 6 Semester 2, PST NTA Level 6, PST06208 Pharmaceutical Public Health

PST06208 Pharmaceutical Public Health – Complete Full Notes

/

NTA Level 6 • Semester 2 • PST06208 Pharmaceutical Public Health – Complete Full Notes Complete educational source text in one page Completeness safeguard: this page keeps the complete educational module/source wording in one place so learning material is not lost when browsing topic by topic. Presenter/tutor metadata is intentionally excluded. | | UNITED REPUBLIC OF TANZANIA [pic] Ministry of Health, Community Development, Gender, Elderly and Children Facilitator Guide Copyright © Ministry of Health, Community Development, Gender, Elderly and Children – 2019 Table of Contents Background iv Acknowledgment v Introduction vii Abbreviations x Session 1: Introduction to Public Health 1 Session 2: Pharmaceutical Public Health 8 Session 3: Introduction to Health Promotion 13 Session 4: Steps in Conducting Health Promotion 22 Session 5: Health Promotion Programmes Related to Pharmaceutical Care and Services 27 Session 6: Introduction to Advocacy 32 Session 7: Techniques in Conducting Advocacy 39 Session 8: Needs Assessment for Advocacy 45 Session 9: Approaches of Conducting Advocacy 50 Session 10: Steps in Conducting Advocacy 54 Session 11: Components of Advocacy Plan 60 Background There is currently an ever increasing demand for pharmaceutical personnel in Tanzania. This is due to expanding investment in public and private pharmaceutical sector. Shortage of trained pharmaceutical human resource contributes to poor quality of pharmaceutical services and low access to medicines in the country (GIZ, 2012). Through Public-Private-Partnership (PPP) the Pharmacy Council (PC) together with Development Partners (DPs) in Germany and Pharmaceutical Training Institutions (PTIs) worked together to address the shortage of human resource for pharmacy by designing a project named “Supporting Training Institutions for Improved Pharmaceutical Services in Tanzania” in order to improve quality and capacity of PTIs in training, particularly of lower cadre pharmaceutical personnel. The Pharmacy Council formed a Steering committee that conducted a stakeholder’s workshop from18th to 22ndAugust 2014 in Morogoro to initiate the implementation of the project. Key activities in the implementation of this project included carrying out situational analysis, curriculum review and harmonization, development of training manual/facilitators guide, development of assessment plan, training of trainers and supportive supervision. After the curricula were reviewed and harmonized, the process of developing standardized training materials was started in August 2015 through Writer’s Workshop (WW) approach. The approach included two workshops (of two weeks each) for developing draft documents and a one-week workshop for reviewing, editing and formatting the sessions of the modules. The goals of Writers Workshops were to build capacity of tutors in the development of training materials and to develop high-quality, standardized teaching materials. The training package for pharmacy cadres includes a Facilitator Guide, Assessment plan and Practicum. There are 12 modules for NTA level 6 making 12 Facilitator guides and one Practicum guide. Acknowledgment The development of standardized training materials of a competence-based curriculum for pharmaceutical sciences has been accomplished through involvement of different stakeholders. Special thanks go to the Pharmacy Council for spearheading the harmonization of training materials in the pharmacy after noticing that training institutions in Tanzania were using different curricula and train their students differently. I would also like to extend my gratitude to Christian Social Service Commission (CSSC) for their tireless efforts to mobilize funds from development partners (German Ministry of Industry and action medeor). It is through the implementation of the Multi-Actors Partnership (MAP) project, CSSC has been able to provide the financial and technical support needed during the development of this training material. Many thanks go to the Centre for Educational Development in Health Arusha (CEDHA) experts on health material development and training who coordinated the development of these module sessions particularly Ms. Diana H. Gamuya for her commitment in coordinating and facilitating the planning and development to its completion. Particular acknowledgements are sent to Mr. Dickson Mtalitinya and Members from the secretariat of National Council for Technical Education (NACTE) for facilitating and providing their expertise to the success of this work. It will be unfair if I will not recognize the efforts and contributions of all CEDHA supportive staff that made this process a success; accountant, secretary, drivers and printers Finally, I very much appreciate the contributions of the tutors and content experts representing PTIs, hospitals, and other health training institutions. Their participation in meetings and workshops, and their input in the development of this training manual/facilitators guide have been invaluable. These participants are listed with our gratitude below: Ms. Elizabeth Shekalaghe Registrar, Pharmacy Council of Tanzania Health,MoHCDGEC Dr. Jacqueline Uriyo Acting Principal, CEDHA Dr. Sungwa N. Kabissi Project Manager – MAP, CSSC Ms. Diana H. Gamuya CEDHA Ms. Grace Mallange PC Ms. Emily Mwakibolwa Pharmacy Council Ms. Tumaini H. Lyombe MUHAS Ms. Dilisi J. Makawia KSP Director of Human Resources Development Ministry of Health, Community Development, Gender, Elderly and Children Introduction Module Overview This module content is a guide for tutors of Pharmaceutical schools for training of students. The session contents are based on sub-enabling outcomes and their related tasks of the curriculum for Basic Technician Course in Pharmaceutical Sciences. The module sub-enabling outcomes and their related tasks are as indicated in the Ordinary Diploma in Pharmaceutical Sciences (NTA Level 6) Curriculum Target Audience This module is intended for use primarily by tutors of pharmaceutical schools. The module’s sessions give guidance on the time, activities and provide information on how to teach the session. The sessions include different activities which focus on increasing students’ knowledge, skills and attitudes. Organization of the Module The module consists of eleven (11) sessions; each session is divided into several parts as indicated below: • Session Title: The name of the session • Total Session Time: The estimated time for teaching the session, indicated in minutes • Pre-requisites: A module or session which needs to be covered before teaching the session. • Learning Tasks: Statements which indicate what the student is expected to learn by the end of the session • Resources Needed: All resources needed for the session are listed including handouts and worksheets • Session Overview: The session overview box lists the steps, time for each step, the activity or method used

Soma Makala →
Pharmaceutical Sciences Notes, PST Level 6 Semester 2, PST NTA Level 6, PST06209 Entrepreneurship

PST06209 Entrepreneurship – Complete Full Notes

/

NTA Level 6 • Semester 2 • PST06209 Entrepreneurship – Complete Full Notes Complete educational source text in one page Completeness safeguard: this page keeps the complete educational module/source wording in one place so learning material is not lost when browsing topic by topic. Presenter/tutor metadata is intentionally excluded. UNITED REPUBLIC OF TANZANIA Ministry of Health, Community Development, Gender, Elderly and Children PST 06209 Entrepreneurship NTA Level 6 Semester 2 Facilitator Guide __________________________________________________________________________________________ PST 06209 Enterpreneurship NTA Level 6 Semester 2 Facilitator Guide March 2019 i Copyright © Ministry of Health, Community Development, Gender, Elderly and Children – 2019 __________________________________________________________________________________________ PST 06209 Enterpreneurship NTA Level 6 Semester 2 Facilitator Guide ii Table of Contents Background ……………………………………………………………………………………………….. iv Acknowledgment ………………………………………………………………………………………. vii Introduction ……………………………………………………………………………………………….. ix Abbreviations ……………………………………………………………………………………………. xii Session 1: Concepts of Entrepreneurship …………………………………………………………1 Session 2: Historical Development and Theories of Entrepreneurship …………………7 Session 3: Importance of Entrepreneurship in the Economy and Pharmacy Profession ………………………………………………………………16 Session 4: National Strategy for Growth and Reduction of Poverty …………………..22 Session 5: Tanzania Development Vision 2025 ………………………………………………31 Session 6: Linkage between National Strategy for Economic Empowerment and Poverty Reduction (NSEGPR) and Vision 2025 ……………………………………………..40 Session 7: Classification of Entrepreneurs ……………………………………………………..46 Session 8: Characteristics of Entrepreneurship ……………………………………………….56 Session 9: Factors Influencing Tendency to Engage in Entrepreneurship …………..67 Session 10: Challenges Encountered by Entrepreneurs in Provision of Pharmaceutical Services ………………………………………………………………………………73 Session 11: The Innovation and Creativity in Entrepreneurship ………………………..79 Session 12: Concepts of Marketing in Sales of Pharmaceuticals ……………………….85 Session 13: Marketing Skills in Sales of Pharmaceuticals ………………………………..93 Session 14: Ethical Issues in Marketing and Sales of Pharmaceuticals ………………99 Session 15: Establishment of Medicines and Medical Supplies Outlets in Tanzania …………………………………………………………………………………………………..106 __________________________________________________________________________________________ PST 06209 Enterpreneurship NTA Level 6 Semester 2 Facilitator Guide iii Background There is currently an ever-increasing demand for pharmaceutical personnel in Tanzania. This is due to expanding investment in public and private pharmaceutical sector. Shortage of trained pharmaceutical human resource contributes to poor quality of pharmaceutical services and low access to medicines in the country (GIZ, 2012). Through Public-Private-Partnership (PPP) the Pharmacy Council (PC) together with Development Partners (DPs) in Germany and Pharmaceutical Training Institutions (PTIs) worked together to address the shortage of human resource for pharmacy by designing a project named “Supporting Training Institutions for Improved Pharmaceutical Services in Tanzania‖ in order to improve quality and capacity of PTIs in training. CSSC prepared a Multi-actor Partnership (MAP) project proposal on how to sustain and strengthen health care in Tanzania through improvement of pharmaceutical training and an inter-institutional coordination of actors. This will harmonize and improve access to quality pharmaceutical service in Tanzania. The project has a various key stakeholders like; CSSC, NACTE, PC, TCU, CEDHA and Pharmaceutical Training Institutions (PTIs). Through this project, few PTIs will receive infrastructural improvements to increase the quantitative and qualitative capacities (CUHAS, RUCU and KSP). Furthermore this project will train Pharmaceutical tutors from different PTIs on teaching and assessment methods in Tanzania and thus improved health delivery through increased qualified human resource. It was also observed that in the previous stakeholder‘s meetings there was a need for the development of training manuals and assessment plans for NTA Level 5 & 6, in order to support the establishment and implementation of the curriculum in PTIs. During MAP kick- off workshop done in February 2018, Stakeholders agreed that there was a need for development of the said manuals and it was among the highest priority in Pharmacy education in Tanzania. Therefore this project aims at developing facilitator‘s guide and assessment plans for NTA Level 5 & 6. Pharmacy Council, CSSC and action medeor developed the Terms of Reference and selected a qualified service provider with experience in material development to develop the mentioned training manuals and assessment plan. Centre for Educational Development in Health Arusha (CEDHA) was selected and offered a contract to develop Facilitators guide for NTA level 5 & 6 and assessment plan. Centre for Educational Development in Health Arusha (CEDHA) was offered a leading role with the instructions to include experts who have developed teaching materials for NTA Level 4. These experts are primarily experienced pharmaceutical and non-pharmaceutical tutors. The mode of operation used by CEDHA to develop facilitator‘s guide and assessment plan was participatory approach which included a number of activities through various workshops such as planning, and orientation of material development. After these preliminary __________________________________________________________________________________________ PST 06209 Enterpreneurship NTA Level 6 Semester 2 Facilitator Guide iv workshops, experts developed materials individually and in-groups. Thereafter, developed draft materials were reviewed, edited and formatted and draft one was finalized and shared to stakeholders for inputs. Finally, CEDHA submitted the finalized Facilitator‘s guides and assessment plans for NTA level 5 and 6 to CSSC for endorsement, printing, dissemination and sharing with relevant authorities. There are 12 modules for NTA level 6 making 12 Facilitator guides and one Practicum guide. __________________________________________________________________________________________ PST 06209 Enterpreneurship NTA Level 6 Semester 2 Facilitator Guide v __________________________________________________________________________________________ PST 06209 Enterpreneurship NTA Level 6 Semester 2 Facilitator Guide vi Acknowledgment The development of standardized training materials of a competence-based curriculum for pharmaceutical sciences has been accomplished through involvement of different stakeholders. Special thanks go to the Pharmacy Council for spearheading the harmonization of training materials in the pharmacy after noticing that training institutions in Tanzania were using different curricula and train their students differently. I would also like to extend my gratitude to Christian Social Service Commission (CSSC) for their tireless efforts to mobilize funds from development partners (German Ministry of Industry and action medeor). It is through the implementation of the Multi-Actors Partnership (MAP) project, CSSC has been able to provide the financial and technical support needed during the development of this training material. Many thanks go to the Centre for Educational Development in Health Arusha (CEDHA) experts on health material development and training who coordinated the development of these module sessions particularly Ms. Diana H. Gamuya for her commitment in coordinating and facilitating the planning and development to its completion. Particular acknowledgements are sent to Mr. Dickson Mtalitinya and Members from the

Soma Makala →
Pharmaceutical Sciences Notes, PST Level 6 Semester 2, PST NTA Level 6, PST06210 Operational Research

PST06210 Operational Research – Complete Full Notes

/

NTA Level 6 • Semester 2 • PST06210 Operational Research – Complete Full Notes Complete educational source text in one page Completeness safeguard: this page keeps the complete educational module/source wording in one place so learning material is not lost when browsing topic by topic. Presenter/tutor metadata is intentionally excluded. UNITED REPUBLIC OF TANZANIA Ministry of Health, Community Development, Gender, Elderly and Children PST 06210 Operational Research NTA Level 6 Semester 2 March 2019 ___________________________________________________________________________ PST 06210 Operational Research NTA Level 6 Semester 2 Facilitator Guide i Copyright © Ministry of Health, Community Development, Gender, Elderly and Children – 2019 ___________________________________________________________________________ PST 06210 Operational Research NTA Level 6 Semester 2 Facilitator Guide ii Table of Contents Background …………………………………………………………………………………………………………………… iv Acknowledgment …………………………………………………………………………………………………………… vi Introduction …………………………………………………………………………………………………………………. viii Abbreviations ………………………………………………………………………………………………………………… xi Session 1: Basic Statistical Concepts …………………………………………………………………………………. 1 Session 2: Basic Biostatistics Data ……………………………………………………………………………………. 7 Session 3: Data Presentation …………………………………………………………………………………………… 13 Session 4: Establishing Trends in Health Care ………………………………………………………………….. 23 Session 5: Basic Concept of Research ……………………………………………………………………………… 32 Session 6:Classification of Research ……………………………………………………………………………….. 36 Session 7: Procedures for Conducting Operational Research ………………………………………………. 48 Session 8: Identification of Research Problem …………………………………………………………………. 55 Session 9: Analysis and Statement of the Problem …………………………………………………………….. 69 Session 10: Literature Review in Research ………………………………………………………………………. 80 Session 11: Research Objectives and Questions ………………………………………………………………… 88 Session 12: Review of Study Types/Designs…………………………………………………………………….. 98 Session 13: Research Sampling …………………………………………………………………………………….. 104 Session 14: Determining Sample Size ……………………………………………………………………………. 117 Session 15: Research Ethics………………………………………………………………………………………….. 124 Session 16: Developing Research Tools …………………………………………………………………………. 131 Session 17: Pre-Testing the Research Tools ……………………………………………………………………. 173 Session 18: Data Collection Plan …………………………………………………………………………………… 182 Session 19: Research Budget ………………………………………………………………………………………… 197 Session 20: Data Collection ………………………………………………………………………………………….. 207 Session 21: Data Collection – Field Work Activities ………………………………………………………… 216 Session 22: Data Processing …………………………………………………………………………………………. 219 Session 23: Data Analysis …………………………………………………………………………………………….. 227 Session 24: Research Report Writing …………………………………………………………………………….. 244 Session 25: Methods for Dissemination of Research Findings ………………………………………….. 260 ___________________________________________________________________________ PST 06210 Operational Research NTA Level 6 Semester 2 Facilitator Guide iii Background There is currently an ever-increasing demand for pharmaceutical personnel in Tanzania. This is due to expanding investment in public and private pharmaceutical sector. Shortage of trained pharmaceutical human resource contributes to poor quality of pharmaceutical services and low access to medicines in the country (GIZ, 2012). Through Public-Private-Partnership (PPP) the Pharmacy Council (PC) together with Development Partners (DPs) in Germany and Pharmaceutical Training Institutions (PTIs) worked together to address the shortage of human resource for pharmacy by designing a project named “Supporting Training Institutions for Improved Pharmaceutical Services in Tanzania‖ in order to improve quality and capacity of PTIs in training. CSSC prepared a Multi-actor Partnership (MAP) project proposal on how to sustain and strengthen health care in Tanzania through improvement of pharmaceutical training and an inter-institutional coordination of actors. This will harmonize and improve access to quality pharmaceutical service in Tanzania. The project has a various key stakeholders like; CSSC, NACTE, PC, TCU, CEDHA and Pharmaceutical Training Institutions (PTIs). Through this project, few PTIs will receive infrastructural improvements to increase the quantitative and qualitative capacities (CUHAS, RUCU and KSP). Furthermore this project will train Pharmaceutical tutors from different PTIs on teaching and assessment methods in Tanzania and thus improved health delivery through increased qualified human resource. It was also observed that in the previous stakeholder‘s meetings there was a need for the development of training manuals and assessment plans for NTA Level 5 & 6, in order to support the establishment and implementation of the curriculum in PTIs. During MAP kick- off workshop done in February 2018, Stakeholders agreed that there was a need for development of the said manuals and it was among the highest priority in Pharmacy education in Tanzania. Therefore this project aims at developing facilitator‘s guide and assessment plans for NTA Level 5 & 6. Pharmacy Council, CSSC and action medeor developed the Terms of Reference and selected a qualified service provider with experience in material development to develop the mentioned training manuals and assessment plan. Centre for Educational Development in Health Arusha (CEDHA) was selected and offered a contract to develop Facilitators guide for NTA level 5 & 6 and assessment plan. Centre for Educational Development in Health Arusha (CEDHA) was offered a leading role with the instructions to include experts who have developed teaching materials for NTA Level 4. These experts are primarily experienced pharmaceutical and non-pharmaceutical tutors. The mode of operation used by CEDHA to develop facilitator‘s guide and assessment plan was participatory approach which included a number of activities through various workshops such as planning, and orientation of material development. After these preliminary ___________________________________________________________________________ PST 06210 Operational Research NTA Level 6 Semester 2 Facilitator Guide iv workshops, experts developed materials individually and in-groups. Thereafter, developed draft materials were reviewed, edited and formatted and draft one was finalized and shared to stakeholders for inputs. Finally, CEDHA submitted the finalized Facilitator‘s guides and assessment plans for NTA level 5 and 6 to CSSC for endorsement, printing, dissemination and sharing with relevant authorities. There are 12 modules for NTA level 6 making 12 Facilitator guides and one Practicum guide. ___________________________________________________________________________ PST 06210 Operational Research NTA Level 6 Semester 2 Facilitator Guide v Acknowledgment The development of standardized training materials of a competence-based curriculum for pharmaceutical sciences has been accomplished through involvement of different stakeholders. Special thanks go to the Pharmacy Council for spearheading the harmonization of training materials in the pharmacy after noticing that training institutions in Tanzania were using different curricula and train their students differently. I would also like to extend my gratitude to Christian Social Service Commission (CSSC) for their tireless efforts to mobilize funds from development partners (German Ministry of Industry and action medeor). It is through the implementation of the Multi-Actors Partnership (MAP) project, CSSC has been able to provide the financial and technical support needed during the development of this training material. Many thanks go to the Centre for Educational Development in Health Arusha (CEDHA) experts on health material development and training who coordinated the development of these module sessions particularly

Soma Makala →
Pharmaceutical Sciences Notes, PST Level 6 Semester 2, PST NTA Level 6, PST06211 Monitoring and Evaluation of Medicine Use

PST06211 Monitoring and Evaluation of Medicine Use – Complete Full Notes

/

NTA Level 6 • Semester 2 • PST06211 Monitoring and Evaluation of Medicine Use – Complete Full Notes Complete educational source text in one page Completeness safeguard: this page keeps the complete educational module/source wording in one place so learning material is not lost when browsing topic by topic. Presenter/tutor metadata is intentionally excluded. UNITED REPUBLIC OF TANZANIA Ministry of Health, Community Development, Gender, Elderly and Children PST 06211 MONITORING AND EVALUATION OF MEDICINE USE NTA Level 6 Semester 2 Facilitator Guide March 2019 NTA Level 6 Semester 2 Facilitator Guide i Copyright © Ministry of Health, Community Development, Gender, Elderly and Children – 2019 PST 06211 Monitoring and Evaluation of Medicines Use NTA Level 6 Semester 2 Facilitator Guide i Table of Contents Background …………………………………………………………………………………………………………………… iii Acknowledgment ……………………………………………………………………………………………………………. v Introduction ………………………………………………………………………………………………………………….. vii Abbreviations ………………………………………………………………………………………………………………… ix Session 1: Introduction to Monitoring and Evaluation …………………………………………………………. 1 Session 3: Assessing Monitoring and Evaluation of PharmaceuticalsServices ……………………… 19 Session 4: Performance Indicators for Monitoring and Evaluation ……………………………………… 31 Session 5: Factors Hindering Monitoring and Evaluation of Medicines Use …………………………. 42 Session 6: Indicators in Monitoring and Evaluation Medicines Use ……………………………………. 47 Session 7: Tools for Monitoring and Evaluation of Medicine Use ………………………………………. 54 Session 8: The Concept of Pharmacovigillance: ……………………………………………………………….. 62 Session 9: Pharmacovigillance Methods ………………………………………………………………………….. 69 Session 10: Documentation of Pharmacovigillance Data ……………………………………………………. 78 Session 11: Reporting Pharmacovigillance Data ………………………………………………………………. 84 Session 12: Introduction to Adverse Drug Reactions (ADRs) …………………………………………….. 91 Session 13: Documentation of ADRs ………………………………………………………………………………. 97 Session 14: Reporting of ADRs …………………………………………………………………………………….. 103 Session 15: Substandard and Counterfeit Medicines ………………………………………………………… 112 Session 16: Detection of Substandard and Counterfeit Medicines ……………………………………… 121 Session 17: Controlling Substandard and Counterfeit Medicines ………………………………………. 131 Session 18: Distribution of Substandard and Counterfeit Medicines ………………………………….. 139 PST 06211 Monitoring and Evaluation of Medicines Use NTA Level 6 Semester 2 Facilitator Guide ii Background There is currently an ever-increasing demand for pharmaceutical personnel in Tanzania. This is due to expanding investment in public and private pharmaceutical sector. Shortage of trained pharmaceutical human resource contributes to poor quality of pharmaceutical services and low access to medicines in the country (GIZ, 2012). Through Public-Private-Partnership (PPP) the Pharmacy Council (PC) together with Development Partners (DPs) in Germany and Pharmaceutical Training Institutions (PTIs) worked together to address the shortage of human resource for pharmacy by designing a project named ―Supporting Training Institutions for Improved Pharmaceutical Services in Tanzania‖ in order to improve quality and capacity of PTIs in training. CSSC prepared a Multi-actor Partnership (MAP) project proposal on how to sustain and strengthen health care in Tanzania through improvement of pharmaceutical training and an inter- institutional coordination of actors. This will harmonize and improve access to quality pharmaceutical service in Tanzania. The project has a various key stakeholders like; CSSC, NACTE, PC, TCU, CEDHA and Pharmaceutical Training Institutions (PTIs). Through this project, few PTIs will receive infrastructural improvements to increase the quantitative and qualitative capacities (CUHAS, RUCU and KSP). Furthermore this project will train Pharmaceutical tutors from different PTIs on teaching and assessment methods in Tanzania and thus improved health delivery through increased qualified human resource. It was also observed that in the previous stakeholder‘s meetings there was a need for the development of training manuals and assessment plans for NTA Level 5 & 6, in order to support the establishment and implementation of the curriculum in PTIs. During MAP kick-off workshop done in February 2018, Stakeholders agreed that there was a need for development of the said manuals and it was among the highest priority in Pharmacy education in Tanzania. Therefore this project aims at developing facilitator‘s guide and assessment plans for NTA Level 5 & 6. Pharmacy Council, CSSC and action medeor developed the Terms of Reference and selected a qualified service provider with experience in material development to develop the mentioned training manuals and assessment plan. Centre for Educational Development in Health Arusha (CEDHA) was selected and offered a contract to develop Facilitators guide for NTA level 5 & 6 and assessment plan. Centre for Educational Development in Health Arusha (CEDHA) was offered a leading role with the instructions to include experts who have developed teaching materials for NTA Level 4. These experts are primarily experienced pharmaceutical and non-pharmaceutical tutors. The mode of operation used by CEDHA to develop facilitator‘s guide and assessment plan was participatory approach which included a number of activities through various workshops such as PST 06211 Monitoring and Evaluation of Medicines Use NTA Level 6 Semester 2 Facilitator Guide iii planning, and orientation of material development. After these preliminary workshops, experts developed materials individually and in-groups. Thereafter, developed draft materials were reviewed, edited and formatted and draft one was finalized and shared to stakeholders for inputs. Finally, CEDHA submitted the finalized Facilitator‘s guides and assessment plans for NTA level 5 and 6 to CSSC for endorsement, printing, dissemination and sharing with relevant authorities. There are 12 modules for NTA level 6 making 12 Facilitator guides and one Practicum guide. PST 06211 Monitoring and Evaluation of Medicines Use NTA Level 6 Semester 2 Facilitator Guide iv Acknowledgment The development of standardized training materials of a competence-based curriculum for pharmaceutical sciences has been accomplished through involvement of different stakeholders. Special thanks go to the Pharmacy Council for spearheading the harmonization of training materials in the pharmacy after noticing that training institutions in Tanzania were using different curricula and train their students differently. I would also like to extend my gratitude to Christian Social Service Commission (CSSC) for their tireless efforts to mobilize funds from development partners (German Ministry of Industry and action medeor). It is through the implementation of the Multi-Actors Partnership (MAP) project, CSSC has been able to provide the financial and technical support needed during the development of this training material. Many thanks go to the Centre for Educational Development in Health Arusha (CEDHA) experts on health material development and training who coordinated the development of these module sessions particularly Ms. Diana H. Gamuyafor her commitment in coordinating and facilitating the planning and

Soma Makala →
Pharmaceutical Sciences Notes, PST Level 4 Semester 1, PST NTA Level 4

PST04101 Dispensing Notes – NTA Level 4

/

NTA LEVEL 4 • SEMESTER 1 PST04101 – Dispensing Complete topic-by-topic notes index Open any topic below to study the source-text notes directly on the website. OPEN COMPLETE FULL NOTES →Session 1: Introduction to DispensingSession 2: Medical PrescriptionSession 3: Interpretation of Various Medical Symbols and Abbreviations in a PrescriptionSession 4: Guidelines on Prescribing MedicinesSession 5: Policies and Guidelines on Prescribing MedicinesSession 6: Prescription ErrorsSession 7: Dispensing Procedures in PharmacySession 8: Determining Quantities of Medicine for DispensingSession 9: Medicines Packaging MaterialsSession 10: Medicines LabelSession 11: Generic and Brand Names of MedicinesSession 12: Giving Appropriate Medicine Information to PatientsSession 13: Adverse Drug Reactions, Drug Overdose and IntoxicationSession 14: Documentation of Medicines and Medical SuppliesSession 15: Rational Use of Medicines (RUM)Session 16: Irrational Prescribing of MedicinesSession 17: Irrational Dispensing of MedicineSession 18: Sections in a Pharmacy Department ← View all Semester 1 modules PDF / OFFLINE NOTES Unataka kutumiwa notes hizi kupitia WhatsApp?Kwa notes zilizopangiliwa vizuri kwa kusoma offline au PDF, bonyeza kitufe hapa chini. Ujumbe wenye Level, Semester, Module na Topic utaandaliwa moja kwa moja.TUMIWA NOTES WHATSAPP WhatsApp: 255620339260

Soma Makala →
Pharmaceutical Sciences Notes, PST Level 4 Semester 1, PST NTA Level 4

PST04102 Disease Control and Prevention Notes – NTA Level 4

/

NTA LEVEL 4 • SEMESTER 1 PST04102 – Disease Control and Prevention Complete topic-by-topic notes index Open any topic below to study the source-text notes directly on the website. OPEN COMPLETE FULL NOTES →Session 1: Concepts of Disease Control and PreventionSession 2: Methods of Controlling Common Air-borne DiseasesSession 3: Methods of Controlling Diseases Transmitted by FaecalSession 4: Methods of Controlling Vector-borne DiseasesSession 5: Methods of Controlling Disease Transmitted by Animal BitesSession 6: Measures to Improve Hygiene and SanitationSession 7: Measures for Preventing Water ContaminationSession 8: Water Treatment MethodsSession 9: Water for Pharmaceutical UseSession 10: Methods for Safe Sewage DisposalSession 11: Health Hazards of Poor Housing and VentilationSession 12: Air Purification in Pharmaceutical SettingsSession 13: Using Antiseptics and DisinfectantsSession 14: Introduction to Common Communicable DiseasesSession 15: Identification of Patients with MalariaSession 16: Identification of Patients with Common ColdSession 17: Identification of Patients with TonsillitisSession 18: Identification of Patients with BronchitisSession 19: Identification of Patients with PneumoniaSession 20: Identification of Patients with AmoebiasisSession 21: Identification of Patients with Typhoid FeverSession 22: Identification of Patients with Food PoisoningSession 23: Identification of Patients with CholeraSession 24: Identification of Patients with AscariasisSession 25: Identification of Patients with ScabiesSession 26: Identification of Patients with DermatophytesSession 27: Identification of Patients with HIV/AIDSSession 28: Identification of Patients with TuberculosisSession 29: Identification of Patients with LeprosySession 30: Identification of Patients with GonorrhoeaSession 31: Identification of Patients with SyphilisSession 32: Identification of Patients with TrichomoniasisSession 33: Identification of Patients with Vaginal CandidiasisSession 34: Introduction to Common Non-communicable DiseasesSession 35: Identification of Patients with HypertensionSession 36: Identification of Patients with DiabetesSession 37: Identification of Patients with Peptic UlcersSession 38: Identification of Patients with AsthmaSession 39: Identification of Patients with Allergic RhinitisSession 40: Prevention and Control of Contamination in PharmaceuticalSession 41: Methods for Disposing Pharmaceutical WastesSession 42: Introduction to Human NutritionSession 43: Managing Patients with Nutritional Deficiency DiseasesSession 44: Specialised Food Therapy ← View all Semester 1 modules PDF / OFFLINE NOTES Unataka kutumiwa notes hizi kupitia WhatsApp?Kwa notes zilizopangiliwa vizuri kwa kusoma offline au PDF, bonyeza kitufe hapa chini. Ujumbe wenye Level, Semester, Module na Topic utaandaliwa moja kwa moja.TUMIWA NOTES WHATSAPP WhatsApp: 255620339260

Soma Makala →
banner
Scroll to Top
Adsterra publisher referral